Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07017322 · ClinicalTrials.gov registry record · NA
Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders
A NA study of Anxiety and Eating Disorders, sponsored by Rogers Behavioral Health.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07017322: Recruiting NA study of Anxiety and Eating Disorders, sponsored by Rogers Behavioral Health.
NCT07017322 is a NA study of Anxiety and Eating Disorders that is actively recruiting participants, run by Rogers Behavioral Health. The registered enrollment target is 30 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07017322, a NA study of Anxiety and Eating Disorders, is actively recruiting participants, sponsored by Rogers Behavioral Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and anxiety symptoms. A secondary aim of the study is to evaluate preliminary effectiveness of the protocol for reducing pre-meal anxiety during the treatment, and explore effects on eating disorder symptoms over the course of the inpatient admission.
Primary Outcome
The percentage of eligible patients approached for recruitment, percentage of recruited patients enrolled, and percentage of enrolled patients completing the study, each as recorded by study staff.
Conditions Studied
Interventions
- DEVICE Alpha-Stim AID
Study Locations (1)
Wisconsin
- Rogers Behavioral Health - Oconomowoc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-06-03 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
What NCT07017322 shows while recruiting
NCT07017322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Alpha-Stim AID is the first listed.
NCT07017322 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07017322 about?
NCT07017322 is a clinical study titled "Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders". The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and an...
What is the current status of trial NCT07017322?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-06-03. Estimated completion is 2027-11-01.
What conditions does trial NCT07017322 study?
This clinical trial studies the following conditions: Anxiety, Eating Disorders.
What interventions are being tested in trial NCT07017322?
The interventions under investigation include: Alpha-Stim AID (DEVICE).
Who is sponsoring clinical trial NCT07017322?
This trial is sponsored by Rogers Behavioral Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07017322 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07017322's enrollment target sits among peer trials
30 300th of 364 higher than 55 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI